Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Harmony Biosciences to Participate in Upcoming Investor Conferences

businesswire.com
HRMY The article announces Harmony Biosciences' participation in upcoming investor conferences. This is a standard corporate announcement and does not provide information to suggest a bullish or bearish outlook on the stock.

Harmony Biosciences to Participate in Upcoming Investor Conferences PLYMOUTH MEETING, Pa.--( BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that Harmony's management team will attend the following upcoming investor conferences.

Leerink Partners Global Healthcare Conference

UBS Biotech Summit

Barclays 28th Annual Global Healthcare Conference

About Harmony Biosciences

Harmony Biosciences is a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases who have unmet medical needs. Driven by novel science, visionary thinking, and a commitment to those who feel overlooked, Harmony Biosciences is nurturing a future full of therapeutic possibilities that may enable patients with rare neurological diseases to truly thrive. Established by Paragon Biosciences, LLC, in 2017 and headquartered in Plymouth Meeting, Pa., we believe that when empathy and innovation meet, a better future can begin; a vision evident in the therapeutic innovations we advance, the culture we cultivate, and the community programs we foster. For more information, please visit www.harmonybiosciences.com.